Extracts Enriched in Different Polyphenolic Families Normalize Increased Cardiac NADPH Oxidase Expression while Having Differential Effects on Insulin Resistance, Hypertension, and Cardiac Hypertrophy in High-Fructose-Fed Rats
- 13 December 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 53 (1) , 151-157
- https://doi.org/10.1021/jf048919f
Abstract
Insulin resistance and oxidative stress act synergistically in the development of cardiovascular complications. The present study compared the efficacy of three polyphenolic extracts in their capacity to prevent hypertension, cardiac hypertrophy, increased production of reactive oxygen species (ROS) by the aorta or the heart, and increased expression of cardiac NAD(P)H oxidase in a model of insulin resistance. Rats were fed a 60%-enriched fructose food and were treated once a day (gavage) for 6 weeks with 10 mL/kg of water only (F group) or the same amount of solution containing a red grape skin polyphenolic extract enriched in anthocyanins (ANT), a grape seed extract enriched in procyanidins and rich in galloylated procyanidins (PRO), or the commercial preparation Vitaflavan (VIT), rich in catechin oligomers. All treatments were administered at the same dose of 21 mg/kg of polyphenols. Our data indicate that (a) the ANT treatment prevented hypertension, cardiac hypertrophy, and production of ROS, (b) the PRO treatment prevented insulin resistance, hypertriglyceridemia, and overproduction of ROS but had only minor effects on hypertension or hypertrophy, while (c) Vitaflavan prevented hypertension, cardiac hypertrophy, and overproduction of ROS. All polyphenolic treatments prevented the increased expression of the p91phox NADPH oxidase subunit. In summary, our study suggest that (a) the pathogeny of cardiac hypertrophy in the fructose-fed rat disease involves both hypertension and hyperproduction of ROS, (b) polyphenolic extracts enriched in different types of polyphenols possess differential effects on insulin resistance, hypertension, and cardiac hypertrophy, and (c) polyphenols modulate the expression of NAD(P)H oxidase. Keywords: Polyphenols; tannins; anthocyanins; galloylated procyanidins; hypertension; cardiac hypertrophy; oxidative stress; NADPH oxidase; insulin resistanceKeywords
This publication has 19 references indexed in Scilit:
- Evidence for a Causal Role of the Renin-Angiotensin System in Vascular Dysfunction Associated With Insulin ResistanceHypertension, 2004
- Relation of fasting insulin related to insertion/deletion polymorphism of angiotensin-converting enzyme-gene and cardiac mass in never-treated patients with systemic hypertensionThe American Journal of Cardiology, 2003
- Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockadeAmerican Journal of Physiology-Renal Physiology, 2003
- Simvastatin Prevents Angiotensin II–Induced Cardiac Alteration and Oxidative StressHypertension, 2002
- Investigation Into the Sources of Superoxide in Human Blood VesselsCirculation, 2000
- Isolation, Identification, and Antioxidant Activity of Three Stilbene Glucosides Newly Extracted from Vitis vinifera Cell CulturesJournal of Natural Products, 1998
- The Accumulation of Stilbene Glycosides inVitisviniferaCell Suspension CulturesJournal of Natural Products, 1996
- Role of Insulin Resistance in Human Disease (Syndrome X): An Expanded DefinitionAnnual Review of Medicine, 1993
- Essential hypertension, metabolic disorders, and insulin resistanceAmerican Heart Journal, 1991
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985